Long ‐term Safety and Efficacy of Mirogabalin in Asian Patients with Diabetic Peripheral Neuropathic Pain

ConclusionThis extension study demonstrated the safety and efficacy of a long ‐term flexible dosing regimen of mirogabalin 10 mg or 15 mg twice daily in patients with DPNP.

Source: Journal of Diabetes Investigation - November 12, 2019 Category: Endocrinology Authors: Masayuki Baba, Norimitsu Matsui, Masanori Kuroha, Yosuke Wasaki, Shoichi Ohwada Tags: Clinical Trial Source Type: research